s6y
Company name or ticker
Search
Veraxa Biotech AG - Post de-SPAC
4
Ziegler Christoph Samuel: Statement of changes in beneficial ownership of securities
Filed
Wednesday, October 21, 2026
Period
Oct 20, 2026
Accession number
0001829126-26-011387
Documents
FORM 4
4
On sec.gov
Filing index
All files
Complete submission text
SGML header